InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
InMed Pharmaceuticals Inc. (INM) is a Biotechnology company based in CA with a market capitalization of $2.9M. Revenue grew 7.5% year-over-year and free cash flow was negative at -$7.8M. This page tracks INM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
CA · 13 employees · IPO May 5, 2014
Valuation
Valuation & price
$1.73as of May 26, 2026· -35.2% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.16
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$2.9M
Market cap
7.5%
Revenue growth (YoY)
34.5%
Gross margin
-$7.8M
Free cash flow (USD)
-$14.1M
Net debt
Net cash position
156.1%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2022 → 2025
Value screen
Graham defensive-investor tests
5
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 6, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 22, 2026Filing
Securities Purchase Agreement Amendment
- Insider buyJul 17, 2026Filing
Insider Buy $2KADAR1 Capital Management, LLC · 10% Owner · $1.6K
- Insider buyJul 16, 2026Filing
Insider Buy $32KVivo Opportunity, LLC · 10% Owner · $31.8K
- 8-K eventJul 10, 2026Filing
Merger Agreement Amendment
- Insider buyJul 2, 2026Filing
Insider Buy $10KVivo Opportunity, LLC · 10% Owner · $10.1K
- Insider buyJun 10, 2026Filing
Insider Buy $392KVivo Opportunity, LLC · 10% Owner · $391.6K
- 8-K eventJun 10, 2026Filing
Regained Nasdaq Compliance
- Insider buyMay 21, 2026Filing
Insider Buy $722KADAR1 Capital Management, LLC · 10% Owner · $721.5K
- 8-K eventMay 19, 2026Filing
Preferred Investment Option
- 8-K eventMay 19, 2026Filing
Merger Agreement
Questions
Frequently asked questions
What is InMed Pharmaceuticals Inc.'s market cap?
InMed Pharmaceuticals Inc. (INM) has a market capitalization of $2.9M.
What is INM's P/E ratio?
A meaningful P/E ratio is not available for INM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is INM's price-to-book (P/B) ratio?
INM trades at 0.16 times book value per share.
Are insiders buying INM stock?
Yes — SEC Form 4 filings show 5 open-market insider buys and 0 sells at InMed Pharmaceuticals Inc. in the last 90 days.
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.